Epigenetic regulation of Epstein-Barr virus: From bench to bedside

被引：0

作者：

Gao, Xiao ^{[1
]}

Yang, Hao-Xu ^{[1
]}

Cheng, Shu ^{[1
]}

Cai, Hua-Man ^{[1
]}

Xiong, Jie ^{[1
]}

Zhao, Wei-Li ^{[1
,2
]}

机构：

[1] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, Natl Res Ctr Translat Med Shanghai, Ruijin Hosp,State Key Lab Med Genom,Sch Med, Shanghai, Peoples R China

[2] Lab Mol Pathol, Pole Rech Sinofrancais Sci Vivant et Genom, Shanghai, Peoples R China

来源：

CLINICAL AND TRANSLATIONAL DISCOVERY | 2024年 / 4卷 / 05期

基金：

中国国家自然科学基金;

关键词：

epigenetic; Epstein-Barr virus; histone; immune escape; metabolic reprogramming; pathogenesis; targeted therapy; NK/T-CELL LYMPHOMA; NASOPHARYNGEAL CARCINOMA; PRIMARY IMMUNODEFICIENCIES; GENE-EXPRESSION; PHASE-II; PROTEIN; TRANSCRIPTION; REVEALS; REACTIVATION; PROMOTERS;

D O I：

10.1002/ctd2.357

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

BackgroundEpstein-Barr virus (EBV) is a double-stranded DNA herpesvirus and establishes life-long infection in 95% of the world's populations.Main bodyEBV is critically involved in multiple diseases. Aberrant signaling pathways, immune escape, and metabolic reprogramming play essential roles in EBV-mediated pathogenesis. However, the underlying mechanisms have not yet been fully elucidated. Here we reviewed recent advances on the epigenetic regulation of EBV pathogenesis, which may translate to potential therapeutic strategies in EBV-associated diseases.ConclusionGrowing evidence has suggested that viral infections reconstruct epigenome to modulate gene expression both in the host and the virus levels. EBV acts as an epigenetic driver in carcinogenesis and mainly refers to DNA methylation, RNA methylation, histone modification, chromatin accessibility, and the three-dimensional (3D) genome structure. image

引用

页数：13

共 50 条

[21] Epstein-Barr virus in tumours
Anagnostopoulos, I
Hummel, M
HISTOPATHOLOGY, 1996, 29 (04) : 297 - 315
[22] Regulation of the latent-lytic switch in Epstein-Barr virus
Kenney, Shannon C.
Mertz, Janet E.
SEMINARS IN CANCER BIOLOGY, 2014, 26 : 60 - 68
[23] Role of oxidative stress in the Epstein-Barr virus lifecycle and tumorigenicity
Zhao, Zixiu
Liu, Wen
Luo, Bing
FUTURE VIROLOGY, 2023, 18 (07) : 465 - 477
[24] Identifying the key regulators orchestrating Epstein-Barr virus reactivation
Wang, Yaohao
Yu, Jingwen
Pei, Yonggang
FRONTIERS IN MICROBIOLOGY, 2024, 15
[25] Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis
Li, Hongde
Liu, Sufang
Hu, Jianmin
Luo, Xiangjian
Li, Namei
Bode, Ann M.
Cao, Ya
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (11): : 1309 - 1318
[26] Inhibition of Epstein-Barr Virus Infection by Lactoferrin
Zheng, Ying
Zhang, Wenling
Ye, Qiurong
Zhou, Yanhong
Xiong, Wei
He, Wei
Deng, Min
Zhou, Ming
Guo, Xiaofang
Chen, Pan
Fan, Songqing
Liu, Xiaoping
Wang, Zhen
Li, Xiaoling
Ma, Jian
Li, Guiyuan
JOURNAL OF INNATE IMMUNITY, 2012, 4 (04) : 387 - 398
[27] Efficient replication of Epstein-Barr virus in stratified epithelium in vitro
Temple, Rachel M.
Zhu, Junjia
Budgeon, Lynn
Christensen, Neil David
Meyers, Craig
Sample, Clare E.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (46) : 16544 - 16549
[28] Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin
Du, Yinping
Yu, Jieshi
Du, Li
Tang, Jun
Feng, Wen-Hai
CANCER LETTERS, 2016, 376 (02) : 240 - 248
[29] Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus
Kim, Kyoung-Dong
Tanizawa, Hideki
De Leo, Alessandra
Vladimirova, Olga
Kossenkov, Andrew
Lu, Fang
Showe, Louise C.
Noma, Ken-ichi
Lieberman, Paul M.
NATURE COMMUNICATIONS, 2020, 11 (01)
[30] The Impact of Epstein-Barr Virus Infection on Epigenetic Regulation of Host Cell Gene Expression in Epithelial and Lymphocytic Malignancies
Leong, Merrin Man Long
Lung, Maria Li
FRONTIERS IN ONCOLOGY, 2021, 11

← 1 2 3 4 5 →